Giornata Mondiale del Diabete: Screening e Dispositivi in Primo Piano nel Dibattito

Giornata Mondiale del Diabete: Screening e Dispositivi in Primo Piano nel Dibattito

11 0

ROMA (ITALPRESS) – Today in Rome, the event “World Diabetes Day 2026” was held, made possible with the non-influencing support of Novo Italia, MOVI, and Roche Diagnostics.
The initiative brought together representatives from institutions, scientific societies, and industry stakeholders to delve into two closely related issues: early diagnosis and equitable access to assistance pathways and necessary technologies across different regions.
The discussion focused on the transition from prevention to assistance. Timely identification of the disease is just the first step. In her opening remarks, Honorable Ilenia Malavasi, Member of the XII Commission of the Chamber of Deputies, highlighted: “Early diagnosis can change the journey for type 1 diabetes patients and their families. It is the duty of institutions to create conditions where preventive and assistance opportunities are accessible in every territory. Engaging with scientific societies and associations helps identify obstacles faced in accessing services.” On this note, the importance of initiating the national pediatric screening program for type 1 diabetes and celiac disease, as stipulated by Law n. 130/2023, was discussed. The challenge now is to translate the regulatory framework into operational pathways in the regions, encompassing the availability of diagnostic tests and the monitoring and care of children with positive outcomes. In this regard, Senator Elena Murelli, Member of the 10th Permanent Commission of the Senate of the Republic, remarked: “Identifying disease risk early means the opportunity for timely intervention, reducing complications in cases of type 1 diabetes and preventing dramatic onset scenarios like diabetic ketoacidosis. However, screening must be accompanied by structured PDTA, adequate information for parents, and effective connections between pediatricians, general practitioners, specialists, and diabetes centers.”
Alongside the issue of screening for type 1 diabetes, the prevention of type 2 diabetes was also addressed, stressing attention to risk factors and potential long-term complications. Particularly, pediatric obesity necessitates early interventions and a sustained care approach as children grow. Malgorzata Wasniewska, President of the Italian Society of Pediatric Endocrinology and Diabetology (SIEDP), emphasized: “Childhood obesity requires timely management to reduce the risk of persisting into adulthood and leading to type 2 diabetes and cardiovascular diseases. The top priority is to address pediatric obesity early with prompt diagnosis, multidisciplinary pathways, and equitable access to care, accompanying the child and family over time.”
Raffaella Buzzetti, President of the Italian Society of Diabetology (SID), also addressed the continuity between early diagnosis and ongoing care: “The priority is to prevent disruption in monitoring and care during the transition from pediatric to adult diabetes care. Shared pathways and personalized support for young individuals are needed. Scientific societies can support the implementation of screening through training, common protocols, and indicators to verify coverage and timely follow-up. Concurrently, early diagnosis of type 2 diabetes must translate into integrated management of cardio-renal-metabolic health aimed at preventing complications.”
The meeting also explored the use of medical devices for glycemic monitoring and, where appropriate, insulin administration. Besides clinical appropriateness and early access to technologies, the discussion included various regional provision methods and updates to devices. Even procurement procedures impact the ability to provide innovative solutions without compromising continuity of care.
On the topic of access to technologies, Salvatore De Cosmo, President of the Association of Diabetologists (AMD), addressed the audience: “The use of technologies certainly requires appropriateness, therapeutic education, and trained professionals. Clinical need should guide access, providing uniform opportunities throughout the country.”
Thus, the day highlighted a common thread between the two panels: the opportunities offered by screening and innovation must correspond to accessible care pathways, adequate supplies, and uniform criteria across regions. Dialogue between institutions, healthcare professionals, associations, and stakeholders remains essential in merging quality and timeliness of care with the safety and innovation of medical devices.

– photo courtesy of Esperia Advocacy –
(ITALPRESS).

Fonte notizia

Related Post